HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Lupus profundus and myelopathy].

AbstractBACKGROUND:
We report a case of myelopathy during the course of lupus profundus that is unique to our knowledge.
CASE-REPORT:
A 29-year-old woman had lupus profundus since 1999, initially associated with thrombopenia (28,000 platelets/mm3) treated with corticosteroids for 6 months. Several nodular eruptions occurred from 1999 to 2004. Antinuclear antibodies were positive at 1/320 to 1/640 and complement C4 fraction was low. While being treated with hydroxychloroquine for a recent flare-up of nodular lesions of lupus profundus, she complained of paraesthesia of the abdominal wall and of the upper and lower limbs, suggestive of a medullary lesion. MRI disclosed an image of acute myelitis at the level of the second cervical vertebra. High doses of corticosteroids were promptly administered intravenously (methylprednisolone bolus) followed by oral prednisone and hydroxychloroquine. Six months later the patient was free of neurologic or cutaneous symptoms.
DISCUSSION:
In the literature, systemic signs are rarely associated with lupus profundus and myelitis has never been reported. Lupus myelitis is a vascular and/or demyelinating and usually segmental lesion of the spinal cord. Neurologic symptoms are those of acute rather than chronic or recurrent transverse myelitis. The prognosis is poor with frequent and severe functional sequelae. Treatment is mainly based on high-dose systemic corticotherapy alone or combined with cyclophosphamide. Our patient responded favourably to early methylprednisolone bolus followed by oral corticosteroids and antimalarial treatment.
CONCLUSION:
Lupus profundus is classically of benign course with only cutaneous involvement, but it may sometimes be a sign of systemic lupus and in rare cases may be associated with severe complications.
AuthorsE Bathelier, F Truchot, J Kanitakis, K Blanc-Lasserre, D Geffroy, T Zenone, B Labeille
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 133 Issue 12 Pg. 985-7 (Dec 2006) ISSN: 0151-9638 [Print] France
Vernacular TitleLupus profond et myélopathie.
PMID17185929 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Dermatologic Agents
  • Hydroxychloroquine
  • Prednisone
  • Methylprednisolone
Topics
  • Acute Disease
  • Adrenal Cortex Hormones (therapeutic use)
  • Adult
  • Dermatologic Agents (therapeutic use)
  • Female
  • Humans
  • Hydroxychloroquine (therapeutic use)
  • Methylprednisolone (therapeutic use)
  • Myelitis (complications, drug therapy)
  • Panniculitis, Lupus Erythematosus (complications, drug therapy)
  • Prednisone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: